Home > Insider Trading > Perrigo Co (Old Filings)

Perrigo Co (Old Filings) (PRGO)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
71 - 80
Next >>

Elan Corporation, plc (ADR) (ELN), Perrigo Company (PRGO): Examining an Acquisition That Benefits This Global Healthcare Supplier

Recently, Elan Corporation, plc (ADR) (NYSE:ELN) ended the fight against bids from Royalty Pharma. Previously, Royalty Pharma had raised its all-cash offer from $5.7 billion to $6.4 billion.

Keep Reading →

August 7th, 2013 - News

Perrigo Company (PRGO), Elan Corporation, plc (ADR) (ELN): This Merger Adds Value Multiple Ways

2013 is turning out to be a stellar year for Mergers and Acquisitions. There have been a number of M&A deals in healthcare and technology sectors.

Keep Reading →

August 6th, 2013 - News

Dell Inc. (DELL), Elan Corporation, plc (ADR) (ELN): You’re a Bad Investor. Here’s How to Get Better.

The chances are good that you're a bad investor.

Keep Reading →

August 5th, 2013 - News

Perrigo Company (PRGO), Elan Corporation, plc (ADR) (ELN): Is This Acquisition a Game Changer?

A patented drug is a cash cow for drug manufacturers. There are two ways to have a patented cash generating drug on a pharmaceutical company’s pipeline.

Keep Reading →

August 5th, 2013 - News

Elan Corporation, plc (ADR) (ELN), Perrigo Company (PRGO): Strange Biotech Bedfellows

When I interviewed Alkermes Plc (NASDAQ:ALKS)' CEO Richard Pops last year, he described the relocation of the company's headquarters to Ireland where taxes are lower after buying Elan Corporation, plc...

Keep Reading →

July 30th, 2013 - News

Perrigo Company (PRGO) to Buy Elan Corporation, plc (ADR) (ELN) for $8.6 Billion

After months of fighting off the advances of unwanted suitor Royalty Pharma, Irish biotech Elan Corporation, plc (ADR) (NYSE:ELN) finally got an offer it couldn't refuse -- from drugmaker Perrigo Company...

Keep Reading →

July 29th, 2013 - News

Abbott Laboratories (ABT), Merck & Co., Inc. (MRK): The Proprietary Drug Business Just Got Riskier

A new Supreme Court ruling presents pharmaceutical companies with a tough choice -- stop paying generic-drug producers to withhold generic options from the market, or risk getting sued by regulators ...

Keep Reading →

June 20th, 2013 - News

Perrigo Company (PRGO): What's The Smart Money Think?

Perrigo Company (NASDAQ:PRGO) was in 24 hedge funds' portfolio at the end of March. PRGO has seen an increase in hedge fund interest in recent months.

Keep Reading →

June 3rd, 2013 - News

Express Scripts Holding Company (ESRX), And More Favs From Janus Fund

Janus Fund (JANDX) bares the name of the fund family behind it. The flagship offering focuses on growth.

Keep Reading →

May 1st, 2013 - Hedge Funds

AbbVie Inc (ABBV)'s First Quarter: The Full Story of Humira And The 7 Dwarfs

In its first four months of existence, AbbVie Inc (NYSE:ABBV) rewarded investors with gains of almost 26%. Going into month five, those gains seem likely to increase.

Keep Reading →

April 29th, 2013 - News